A: Flat Base detected on 26 Jun 2026

Agilent is forming a flat base pattern at $135.51, just 4.2% below resistance at $141.09 and well clear of support at $115.02 (20.5 points below current price). The pattern displays strong structure (15/15) and solid breakout mechanics (12/13), though volume support is moderate at 9/12 with current volume trailing 20-day average by 25%. Technical posture is neutral-to-slightly-bullish: RSI at 63.06 suggests room to run before overbought, MACD histogram is negative (-0.3748) but not severely, and price sits 70.4% through Bollinger Band width, indicating consolidation rather than capitulation. Overall pattern score of 80 with 66.84% win probability reflects a credible setup.

Agilent reported Q2 2026 revenue of $1.83-1.84 billion, up 10% reported and 6.3% core YoY, with diluted EPS of $1.20 versus $0.75 in Q2 2025. Revenue growth was broad-based: Life Sciences & Diagnostics rose 12% QoQ, Agilent CrossLab was up 6%, and Applied Markets increased 14%. The stock broke out sharply on May 28, 2026, closing at $115.84 the prior day then ripping to $135.38, a 17% single-session move. Gross margins are running around 52.2% and EBIT margins near 21.8%, top-tier for a hardware-heavy lab tools company. Analyst coverage shows 13 Buy ratings and 2 Hold ratings with no Sells among 15 recent analysts. The stock is now consolidating gains ~$20 above the breakout entry zone, building a base that allows pattern-trained traders to enter with defined risk.

A successful flat base breakout above $141.09 resistance would target the conservative measured move of $141.38—approximately $0.30 higher, a modest initial target typical of base breakouts. More meaningfully, historical patterns suggest the stock could extend toward the $155 zone based on breakout momentum and analyst price targets clustering around $155-160. For confirmation, breakout volume should exceed the current 0.75x ratio, ideally reaching 1.1-1.3x of 20-day average (3.0-3.6M shares). The setup fails decisively if price closes below key support at $115.02, which represents the lower bound of the base and the prior consolidation zone. The 66.84% win probability provides reasonable odds for a continuation pattern in a bullish regime (0.95 market score, 0.91 sector score).

Volume is currently a weakness: 2.03M shares traded versus 2.72M average, suggesting fresh buying interest has not yet confirmed the breakout. MACD histogram at -0.3748 indicates momentum is still negative despite price strength, a potential divergence warning. Beta of 1.02 is neutral but market-dependent—if broad indices roll over, Agilent will follow. The stock is -15.12% below its 52-week high at $160.27, meaning it has retreated and is rebuilding, not pushing to new highs. No near-term earnings catalyst exists post-May 27 beats, so the next driver will be organic execution or sentiment shifts; any negative data on diagnostics or lab spending could halt this base-building. Finally, dividend ex-date on June 30 is imminent, which may trigger profit-taking from dividend-capture traders.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.